For US biotech startups in 2026, robust intellectual property protection is paramount to secure innovations, attract investment, and maintain competitive advantage in a rapidly evolving market landscape.

For US biotech startups navigating 2025, robust intellectual property protection is paramount. This article outlines practical strategies to avoid common pitfalls, ensuring your innovations are safeguarded against infringement and competitive threats.